These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

303 related items for PubMed ID: 10525091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Increased mitochondrial K(ATP) channel activity during chronic myocardial hypoxia: is cardioprotection mediated by improved bioenergetics?
    Eells JT, Henry MM, Gross GJ, Baker JE.
    Circ Res; 2000 Nov 10; 87(10):915-21. PubMed ID: 11073888
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. YM934, a novel K+ channel opener, activates ATP-sensitive K+ channels in cardiac myocytes.
    Yamada M, Terzic A, Findlay I, Jahangir A, Shen WK, Kurachi Y.
    J Pharmacol Exp Ther; 1993 Dec 10; 267(3):1544-9. PubMed ID: 8263816
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacologic profiles of YM934, a novel potassium channel opener.
    Uchida W, Masuda N, Taguchi T, Shibasaki K, Shirai Y, Asano M, Matsumoto Y, Tsuzuki R, Fujikura T, Takenaka T.
    J Cardiovasc Pharmacol; 1994 Feb 10; 23(2):180-7. PubMed ID: 7511745
    [Abstract] [Full Text] [Related]

  • 9. ATP-dependent potassium channels involved in the cardiac protection induced by intermittent hypoxia against ischemia/reperfusion injury.
    Zhu HF, Dong JW, Zhu WZ, Ding HL, Zhou ZN.
    Life Sci; 2003 Jul 25; 73(10):1275-87. PubMed ID: 12850243
    [Abstract] [Full Text] [Related]

  • 10. Polyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat hearts.
    Song DK, Jang Y, Kim JH, Chun KJ, Lee D, Xu Z.
    J Korean Med Sci; 2010 Mar 25; 25(3):380-6. PubMed ID: 20191036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mitochondria are targets for geranylgeranylacetone-induced cardioprotection against ischemia-reperfusion in the rat heart.
    Shinohara T, Takahashi N, Kohno H, Yamanaka K, Ooie T, Wakisaka O, Murozono Y, Taniguchi Y, Torigoe Y, Hara M, Shimada T, Saikawa T, Yoshimatsu H.
    Am J Physiol Heart Circ Physiol; 2007 Sep 25; 293(3):H1892-9. PubMed ID: 17586615
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Opioid-induced cardioprotection against myocardial infarction and arrhythmias: mitochondrial versus sarcolemmal ATP-sensitive potassium channels.
    Fryer RM, Hsu AK, Nagase H, Gross GJ.
    J Pharmacol Exp Ther; 2000 Aug 25; 294(2):451-7. PubMed ID: 10900218
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.
    Grover GJ, D'Alonzo AJ, Garlid KD, Bajgar R, Lodge NJ, Sleph PG, Darbenzio RB, Hess TA, Smith MA, Paucek P, Atwal KS.
    J Pharmacol Exp Ther; 2001 Jun 25; 297(3):1184-92. PubMed ID: 11356945
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Mitochondrial K(ATP) channel as an end effector of cardioprotection during late preconditioning: triggering role of nitric oxide.
    Wang Y, Kudo M, Xu M, Ayub A, Ashraf M.
    J Mol Cell Cardiol; 2001 Nov 25; 33(11):2037-46. PubMed ID: 11708847
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.